Literature DB >> 10572102

CD38 triggers cytotoxic responses in activated human natural killer cells.

G Sconocchia1, J A Titus, A Mazzoni, A Visintin, F Pericle, S W Hicks, F Malavasi, D M Segal.   

Abstract

Receptors used by natural killer (NK) cells to mediate natural cytotoxicity are poorly defined, although it is now clear that a number of adhesion molecules can serve this function. CD38 transduces signals on T- and B-cell lines, and we asked whether it could trigger lytic and secretory responses in human NK cells. By using an anti-CD38 monoclonal antibody in reverse antibody-dependent cellular cytotoxicity experiments, it is shown that CD38 engagement triggers cytotoxic responses by activated NK cells, but not by cytotoxic T lymphocytes or fresh NK cells. Cross-linking with anti-CD38 F(ab')(2) caused activated NK cells to release granzymes and cytokines, but did not trigger an increase in intracellular Ca(2+). Fresh NK cells acquired CD38-dependent lytic function during activation with interleukin-2 (IL-2), and inhibitor studies suggested that IL-2 stimulated the de novo expression of proteins that act between CD38 and the lytic machinery in NK cells. The induction of proteins that link commonly expressed adhesion molecules to effector mechanisms could provide a paradigm for pathogen recognition by the innate immune system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572102

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.

Authors:  E L Azeredo; L M De Oliveira-Pinto; S M Zagne; D I S Cerqueira; R M R Nogueira; C F Kubelka
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells.

Authors:  Maria C Ochoa; Elisabeth Perez-Ruiz; Luna Minute; Carmen Oñate; Guiomar Perez; Inmaculada Rodriguez; Aintzane Zabaleta; Diego Alignani; Myriam Fernandez-Sendin; Ascension Lopez; Aura Muntasell; Miguel F Sanmamed; Bruno Paiva; Miguel Lopez-Botet; Pedro Berraondo; Ignacio Melero
Journal:  Oncoimmunology       Date:  2019-04-13       Impact factor: 8.110

3.  Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel.

Authors:  Vivek Naranbhai; Salim S Abdool Karim; Marcus Altfeld; Natasha Samsunder; Raveshni Durgiah; Sengeziwe Sibeko; Quarraisha Abdool Karim; William H Carr
Journal:  J Infect Dis       Date:  2012-07-24       Impact factor: 5.226

4.  The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.

Authors:  Subhashis Sarkar; Sachin K S Chauhan; John Daly; Alessandro Natoni; Heather Fairfield; Robert Henderson; Emma Nolan; Dawn Swan; Jinsong Hu; Michaela R Reagan; Michael O'Dwyer
Journal:  Cancer Immunol Immunother       Date:  2020-01-09       Impact factor: 6.968

5.  Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo-Expanded Autologous NK Cells.

Authors:  Yufeng Wang; Yibo Zhang; Tiffany Hughes; Jianying Zhang; Michael A Caligiuri; Don M Benson; Jianhua Yu
Journal:  Clin Cancer Res       Date:  2018-04-17       Impact factor: 12.531

6.  HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype.

Authors:  Shuying S Li; Andrew Hickey; Shida Shangguan; Philip K Ehrenberg; Aviva Geretz; Lauryn Butler; Gautam Kundu; Richard Apps; Matthew Creegan; Robert J Clifford; Suteeraporn Pinyakorn; Leigh Anne Eller; Pikunchai Luechai; Peter B Gilbert; Timothy H Holtz; Anupong Chitwarakorn; Carlo Sacdalan; Eugène Kroon; Nittaya Phanuphak; Mark de Souza; Jintanat Ananworanich; Robert J O'Connell; Merlin L Robb; Nelson L Michael; Sandhya Vasan; Rasmi Thomas
Journal:  Cell Host Microbe       Date:  2022-07-15       Impact factor: 31.316

7.  Dual role of CD38 in microglial activation and activation-induced cell death.

Authors:  Lior Mayo; Jasmine Jacob-Hirsch; Ninette Amariglio; Gideon Rechavi; Marie-Jo Moutin; Frances E Lund; Reuven Stein
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

Authors:  Liat Binyamin; R Katherine Alpaugh; Tracey L Hughes; Charles T Lutz; Kerry S Campbell; Louis M Weiner
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

9.  Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.

Authors:  Brian R Long; Lishomwa C Ndhlovu; Jorge R Oksenberg; Lewis L Lanier; Frederick M Hecht; Douglas F Nixon; Jason D Barbour
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

10.  T-Cell Immune Imbalance in Rheumatoid Arthritis Is Associated with Alterations in NK Cells and NK-Like T Cells Expressing CD38.

Authors:  Hongxing Wang; Kehua Fang; Weining Yan; Xiaotian Chang
Journal:  J Innate Immun       Date:  2021-08-24       Impact factor: 7.111

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.